Previous close | 0.9000 |
Open | 0.5700 |
Bid | 0.5500 |
Ask | 0.6000 |
Strike | 127.00 |
Expiry date | 2024-05-24 |
Day's range | 0.5600 - 0.7100 |
Contract range | N/A |
Volume | |
Open interest | 63 |
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
Matthew Dolan, Executive Vice President of Strategy and Corporate Development at DexCom Inc (NASDAQ:DXCM), sold 2,423 shares of the company on May 15, 2024.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.